NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,176 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $891,922 | +2.9% | 8,378 | -6.5% | 0.82% | +1.4% |
| Q1 2024 | $866,798 | -11.0% | 8,961 | -7.1% | 0.81% | -18.3% |
| Q4 2023 | $973,957 | -12.3% | 9,646 | -11.5% | 0.99% | -10.2% |
| Q3 2023 | $1,110,376 | -1.5% | 10,901 | -2.4% | 1.10% | +5.2% |
| Q2 2023 | $1,126,761 | +8.0% | 11,166 | -1.5% | 1.05% | +6.1% |
| Q1 2023 | $1,043,096 | -1.2% | 11,338 | -2.6% | 0.99% | -6.2% |
| Q4 2022 | $1,055,799 | – | 11,638 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |